Bruce D. Cohen
- Molecular Biology
- Oncology top 10%
- Endocrinology, Diabetes and Metabolism top 10%
- Neurology top 10%
- Radiology, Nuclear Medicine and Imaging top 10%
- Co-authors
- Douglas R. LowyJeffrey E. DeClueH. Perry FellCatherine SoderstromMark W. TengowskiAntonio GualbertoJohn T. SchillerDeborah A. Baker
- Topics
- Monoclonal and Polyclonal Antibodies Research (4 papers)Virus-based gene therapy research (3 papers)HER2/EGFR in Cancer Research (3 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryMolecular and Cellular Biology
- Partner nations
- United StatesGermanyAustralia
In The Last Decade
Bruce D. Cohen
12 papers receiving 781 citations
Peers
Comparison fields: 5 of 62
- Molecular Biology 420
- Oncology 322
- Endocrinology, Diabetes and Metabolism 181
- Neurology 160
- Radiology, Nuclear Medicine and Imaging 154
Countries citing papers authored by Bruce D. Cohen
This map shows the geographic impact of Bruce D. Cohen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce D. Cohen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce D. Cohen more than expected).
Fields of papers citing papers by Bruce D. Cohen
This network shows the impact of papers produced by Bruce D. Cohen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce D. Cohen. The network helps show where Bruce D. Cohen may publish in the future.
Co-authorship network of co-authors of Bruce D. Cohen
This figure shows the co-authorship network connecting the top 25 collaborators of Bruce D. Cohen. A scholar is included among the top collaborators of Bruce D. Cohen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce D. Cohen. Bruce D. Cohen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | Targeting the IGF1R signaling pathway: Clinical implications | 1 |
| 3 | 287 | |
| 4 | 19 | |
| 5 | 108 | |
| 6 | 74 | |
| 7 | 20 | |
| 8 | 15 | |
| 9 | 31 | |
| 10 | 74 | |
| 11 | 171 | |
| 12 | 9 |
About Bruce D. Cohen
Bruce D. Cohen is a scholar working on Immunology and Allergy, Radiology, Nuclear Medicine and Imaging and Oncology, having authored 12 papers that have together received 810 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (4 papers), Virus-based gene therapy research (3 papers) and HER2/EGFR in Cancer Research (3 papers). The work is most often cited by research in Oncology (322 citations), Endocrinology, Diabetes and Metabolism (181 citations) and Neurology (160 citations). Bruce D. Cohen has collaborated with scholars based in United States, Germany and Australia. Frequent co-authors include Douglas R. Lowy, Jeffrey E. DeClue, H. Perry Fell, Catherine Soderstrom, Mark W. Tengowski, Antonio Gualberto, John T. Schiller, Deborah A. Baker, Faye Wang and Jean S. Beebe. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Molecular and Cellular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.